Catherine Vasilakis-Scaramozza, Ph.D.

Affiliations: 
2009 Boston University, Boston, MA, United States 
Area:
Public Health, Obstetrics and Gynecology
Google:
"Catherine Vasilakis-Scaramozza"
Cross-listing: PHTree

Parents

Sign in to add mentor
Susan S. Jick grad student 2009 Boston University
 (The prevalence of congenital anomalies in the offspring of users of common prescription medications.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Persson R, Hagberg KW, Qian Y, et al. (2020) The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids. Rheumatology (Oxford, England)
Persson R, Vasilakis-Scaramozza C, Hagberg KW, et al. (2020) CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities. Pharmacoepidemiology and Drug Safety
Persson R, Hagberg KW, Qian EY, et al. (2020) The risk of myocardial infarction, stroke and revascularization among patients with psoriasis treated with apremilast compared to biologics and DMARDs: a cohort study in the United States MarketScan database. Journal of the American Academy of Dermatology
Jick SS, Hagberg KW, Persson R, et al. (2020) Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism. Pharmacoepidemiology and Drug Safety
Hagberg KW, Persson R, Vasilakis-Scaramozza C, et al. (2020) Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis. Clinical Epidemiology. 12: 153-161
Vasilakis-Scaramozza C, Persson R, Hagberg KW, et al. (2020) The risk of treated anxiety and treated depression among patients with psoriasis and PsA treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database. Journal of the European Academy of Dermatology and Venereology : Jeadv
Vasilakis-Scaramozza C, Aschengrau A, Cabral H, et al. (2013) Antidepressant use during early pregnancy and the risk of congenital anomalies. Pharmacotherapy. 33: 693-700
Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, et al. (2013) Antihypertensive drugs and the risk of congenital anomalies. Pharmacotherapy. 33: 476-82
Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, et al. (2013) Asthma drugs and the risk of congenital anomalies. Pharmacotherapy. 33: 363-8
Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. (2003) Validity of the general practice research database. Pharmacotherapy. 23: 686-9
See more...